Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
crispr
4
×
deals
4
×
life sciences
national blog main
biotech
boston blog main
boston top stories
gene editing
national top stories
san francisco blog main
boston
cancer
car-t
clinical trials
editas medicine
gene therapy
national
novartis
pfizer
san francisco top stories
vc
abbvie
acquisitions
administration
advanced therapies
allergan
alzheimer's
alzheimer's disease
amgen
atmp
avexis
bellicum pharmaceuticals
biogen
biomarin pharmaceutical
biontech
bioprocess insider
bms
boulder/denver blog main
boulder/denver top stories
brammer bio
What
gene
4
×
bio
crispr
editing
medicines
therapy
abbvie
access
advanced
alliance
becker
billions
biotech
capacity
car
cell
consolidation
create
diagnostic
diseases
dollars
eaton
editas
exits
experimental
falcon
fix
focus
genetic
healthcare
heats
high
human
impact
launches
life
michael
milestones
millions
moves
Language
unset
Current search:
gene
×
crispr
×
deals
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M